Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by MrMonkon Oct 18, 2014 12:01pm
140 Views
Post# 23040499

RE:RE:RE:Growing Up

RE:RE:RE:Growing UpFrom Dale:

Production decisions are complicated and every deposit is different. Until you outline the entire deposit you don’t know how much gold there is or how big a mill to build. If you build one too small and find more gold then you have to revise or expand construction and that can be costly. A feasibility study can un-earth costs that were not anticipated, such as extraction problems, continuity of the deposit, etc, so amount of gold in the deposit is only one of many considerations.
 
The Marban Block deposits (Marban, Kierens and Norlartic) have all produced before, so that is a good sign. These deposits can make money. Initially, it looks like all 3 can be produced from open pits, and that will reduce costs and increase potential profitability. The grade at Marban is higher than what Osisko (now Agnico and Yamana) are producing right across the road – another good sign.
 
We currently have over 2,000,000 ounces outlined – and that would normally be enough to start moving toward production. But all three deposits are open along trend and at depth, so it is pre-mature to be looking at production. If we end up with 3,000,000 or more ounces, that would change the size of mill required. A quick decision might also result in building the mill in the wrong location – right on top of a key part of the deposit for example.
 
NioGold’s strength is its property and people – we have a well respected group of geologists and strong local ties. This has served us well in acquiring key properties from local prospectors. We are explorers with one of the largest land packages in one of the top gold producing regions on earth. We have huge potential for additional discoveries. But production is a different game, and exploration companies do not often become producers. You need different expertise. You will notice we have recently added key management to the company. New President Robert Wares and Directors Sean Roosen and John Burzynski are some of the top mining men in Canada if not the world. They will help gain NioGold the exposure to top mining funds and executives around the world, as well as guide the company towards the proper decision on exploration and eventual production. They are reviewing our properties, drill plans, and developing a corporate strategy that should be complete soon. NioGold’s annual meeting on October 30 will be the start of a new era in the Company’s progression.

-- MM
<< Previous
Bullboard Posts
Next >>